|4Jul 12, 8:42 AM ET

Jin David 4

4 · Fortress Biotech, Inc. · Filed Jul 12, 2024

Insider Transaction Report

Form 4
Period: 2024-07-10
Jin David
Chief Financial Officer
Transactions
  • Purchase

    SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK

    2024-07-10$7.50/sh+500$3,750500 total

Documents

1 file
  • 4
    tm2419335-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT